First implicated in the development of malignant mesothelioma and uveal melanoma, germline BRCA1-associated protein-1 (BAP1) mutations are a relatively recently discovered tumor predisposition syndrome [40]. The gene discussed is BAP1; the disease is malignant mesothelioma.